Canada Infection Control Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Disinfectants, Sterilization (Low-Temperature Sterilization, Heat Sterilization, Contract Sterilization)), By End User Industry (Healthcare, Food And Beverage, Chemical) - Forecasts From 2022 To 2027

The Canadian infection control market is projected to grow at a CAGR of 6.45% during the forecast period to reach a market value of US$577.209 million in 2027. The market was valued at US$372.691 million in 2020.

 A rise in the aging demographics and a surge in chronic conditions amongst Canadians, together with increased turnover of hospital rooms, has necessitated the Canadian healthcare sector to equip itself with a range of infection control products in Canada.

Increasing infection cases in the country

A decent proportion of patients who are receiving healthcare in Canada get infected every year due to what the World Health Organization (WHO) defines as nosocomial infections. This requires the infection prevention procedures to be even more stringent and rigorous. Therefore, to be in tandem with the healthcare industry, Clorox Healthcare Canada, which offers a portfolio of surface cleaner disinfectants, in addition to UV technology, to provide healthcare facilities with a comprehensive approach to environmental hygiene in efforts to prevent hospital-borne infections, has bolstered its research surrounding microbiology, sporicidal agents, and infection prevention.

Innovative products for hospitals

This has resulted in a stream of innovative new products specifically for the hospital environment, including Clorox Healthcare® Hydrogen Peroxide Cleaner Disinfectant Wipes, Clorox Healthcare® Bleach Germicidal Wipes, and Clorox Healthcare® Fusion™ Cleaner Disinfectant, a next-generation bleach product combining disinfecting efficacy against pathogens with broad surface compatibility.

Further, another factor that is poised to set an upward trend for the Canadian Infection Control Market is the increasing use of sanitizers both in residential premises as well as in healthcare facilities. Plus, due to the growing number of surgeries, the total number of stays in hospitals is also increasing, creating a high chance of contracting an infection. This necessitates an active adherence to sterilization and disinfection procedures in various kinds of healthcare points throughout the country.

Regulatory compliances to enhance the instrumentation and devices

Further, due to stringent regulatory compliance and the inclusion of technically enhanced instruments, there has been a growing need for advanced sterilizers that are tailor-made for these devices, which in turn is leading to more investment in research and development that has led to the growing adoption of low-temperature sterilizers with their wide range of technologies such as ethylene oxide (EtO), vaporized hydrogen peroxide (VHP), hydrogen peroxide gas plasma, and ozone gas-based sterilization. TSO3 Inc.

 (TSX: TOS), an innovator in sterilization technology for medical devices announced it has entered into a binding US$20 million debt financing with Courage Capital Management LLC, an investment advisor, to fund commercialization initiatives for TSO3’s STERIZONE® VP4 Sterilizer, the only terminal sterilization method that is FDA cleared to sterilize multi-channelled flexible endoscopes (with a maximum of four channels) of up to 3.5 meters in length, such as certain colonoscopes, gastroscopes, and duodenoscopes. Therefore, it could be discerned with certainty that the agreements and launches are the results of the increasing need for infection control devices, which are poised to fuel the Canadian Infection Control Market during the forecast period.

Key Developments

• February 2022: IPAC Canada and Queen's University have teamed together to offer specialised training in Infection Prevention and Control (IPAC) through a brand-new IPAC track in the Master of Public Health (MPH) programme. It offers specialised training that equips students with the knowledge and skills needed to lead others and maintain patient, employee, and public safety.
• March 2022: The Sotera Health Company, a premier international supplier of vital lab testing, advisory services, and critical end-to-end sterilising solutions for the healthcare sector, announced the opening of the Sotera Health Academy. To assist businesses in reducing regulatory risk and accelerating the time to market for new products, Sotera Health's three firms—Nelson Labs, Sterigenics, and Nordion—have combined their material under The Academy.

Impact of the COVID-19 pandemic on Canada Infection Control Market

The COVID-19 pandemic led to a major disruption in commercial and industrial activities, owing to the stringent lockdown and social distancing protocols. Since the COVID-19 virus spreads through the air or through contact, the demand for the infection control market grew significantly. Demand for sterilization and disinfection activities in hospitals, residential areas, and public spaces increased significantly due to the outbreak. Hence, the COVID-19 pandemic had a positive impact on the infection control market.

Canada Infection Control Market Scope:

Segmentation

• By Product
  • Disinfectants
  • Sterilization
    • Low-Temperature Sterilization
    • Heat Sterilization
    • Contract Sterilization
• By End User Industry
  • Healthcare
  • Food and Beverage
  • Chemical